Intrathecal Drug Delivery System (IDDS) for Cancer Pain Management: A Review and Updates

被引：19
作者：
Upadhyay, Surjya Prasad [1 ]
Mallick, Piyush N. [2 ]
机构：
[1] Al Jahra Hosp, Minist Hlth, Dept Anaesthesiol Crit Care & Pain Management, Salmiya, State Of Kuwait, Kuwait
[2] Al Jahra Hosp, Minist Hlth, Dept Anaesthesia Crit Care & Pain Management, Salmiya, State Of Kuwait, Kuwait
来源：
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE | 2012年 / 29卷 / 05期
关键词：
cancer pain; intrathecal analgesia; intrathecal drug delivery system; interventional pain management; conventional medical management; SPINAL-CORD; CLONIDINE HYDROCHLORIDE; NONMALIGNANT PAIN; BUPIVACAINE HYDROCHLORIDE; MORPHINE INFUSION; INFLAMMATORY MASS; STABILITY; PATIENT; RELIEF; THERAPY;
D O I：
10.1177/1049909111426134
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
Cancer pain remains undertreated and a significant number of patients with cancer pain die from severe untreated pain. With increasing survival rate in cancer, the prevalence of cancer pain is also increasing in number. Though majority of patients with cancer pain can be effectively treated with conventional medical management, still a significant portion of patients required some form of interventional pain management techniques. Among the interventional techniques, intrathecal drug delivery is increasingly used in cancer pain management. Our objective of this article is to review literatures and clinical studies on intrathecal drug delivery system (IDDS) in cancer pain management and to provide updates on its use, precautions, contraindications, side effects and its management, socioeconomic consideration, and management of IDDS in difficult or uncommon situations.
引用
收藏
页码：388 / 398
页数：11
相关论文
共 89 条
  • [51] ONOFRIO BM, 1981, MAYO CLIN PROC, V56, P516
  • [52] Intraspinal morphine for chronic pain: A retrospective, multicenter study[J]. Paice, JA;Penn, RD;Shott, S. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1996(02)
  • [53] Patel VB, 2009, PAIN PHYSICIAN, V12, P345
  • [54] Evaluation of patients for implantable pain modalities: Medical and behavioral assessment[J]. Prager, J;Jacobs, M. CLINICAL JOURNAL OF PAIN, 2001(03)
  • [55] Raffaeli W, 2011, PAIN PHYSICIAN, V14, P15
  • [56] Rauck R., 2005, ASRA C P, P17
  • [57] A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain[J]. Rauck, Richard L.;Wallace, Mark S.;Leong, Michael S.;MineHart, Michael;Webster, Lynn R.;Charapata, Steven G.;Abraham, Jacob E.;Buffington, Daniel E.;Ellis, David;Kartzinel, Ronald. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2006(05)
  • [58] THE USE OF COPING STRATEGIES IN CHRONIC LOW-BACK-PAIN PATIENTS - RELATIONSHIP TO PATIENT CHARACTERISTICS AND CURRENT ADJUSTMENT[J]. ROSENSTIEL, AK;KEEFE, FJ. PAIN, 1983(01)
  • [59] Geriatric Index of Comorbidity: validation and comparison with other measures of comorbidity[J]. Rozzini, R;Frisoni, GB;Ferrucci, L;Barbisoni, P;Sabatini, T;Ranieri, P;Guralnik, JM;Trabucchi, M. AGE AND AGEING, 2002(04)
  • [60] Stability of clonidine in clonidine-hydromorphone mixture from implanted intrathecal infusion pumps in chronic pain patients[J]. Rudich, Z;Peng, P;Dunn, E;McCartney, C. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2004(06)
123456789